V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004853 | 290003553 | null | null | Palliative (P) | null | 2017-01-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290021915 | CISPLATIN + FLUOROURACIL |
| 290004854 | 290003553 | 1.68 | null | Curative (C) | 2014-01-25 | 2014-02-13 | Bevacizumab + Oxaliplatin +MdG | N | Y | 290021915 | IRINOTECAN + MDG |
| 290004855 | 290003553 | 1.54 | 45.3 | null | 2017-06-25 | 2017-07-02 | Carboplatin + Etoposide iv&po | 02 | N | 290021915 | FLUOROURACIL |
| 290004856 | 290003554 | null | 54.9 | Palliative (P) | 2017-12-19 | 2017-12-29 | Capecitabine | N | N | 290021921 | CISPLATIN + FLUOROURACIL |
| 290004857 | 290003555 | null | 72.2 | Disease modification (D) | 2018-06-19 | 2018-06-19 | Carboplatin + Pemetrexed | N | N | 290021927 | CAPECITABINE + RT |
| 290004858 | 290003556 | 1.6 | 59 | Curative (C) | 2016-08-10 | 2016-08-28 | CETUXIMAB + IRINOTECAN + MDG | 01 | Y | 290021928 | LANREOTIDE |
| 290004859 | 290003557 | null | 46.2 | Not known (9) | 2015-06-05 | 2015-06-25 | EOX | N | N | 290021930 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004860 | 290003558 | 1.65 | 80.6 | null | null | 2015-07-13 | Fluorouracil 96hr infusion+R(4g/m2) | N | Y | 290021931 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290004861 | 290003558 | null | 67.7 | Neo-adjuvant (N) | 2017-05-30 | 2017-06-07 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021931 | TRIAL |
| 290004862 | 290003559 | null | 65.1 | Palliative (P) | null | 2017-12-14 | Y-90 | N | N | 290021934 | ECX |
| 290004863 | 290003560 | 1.6 | 78.2 | Curative (C) | 2015-01-24 | 2015-02-17 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290021936 | GEMCITABINE |
| 290004864 | 290003560 | 1.62 | 87.6 | Palliative (P) | 2016-04-12 | 2016-04-27 | Capecitabine + Cisplatin + RT | N | N | 290021936 | CAPECITABINE |
| 290004865 | 290003561 | 1.53 | 67.3 | Neo-adjuvant (N) | 2016-03-20 | 2016-04-14 | LANREOTIDE | N | N | 290021938 | LANREOTIDE |
| 290004866 | 290003562 | null | null | Curative (C) | 2015-10-04 | 2015-10-30 | Carboplatin + Etoposide iv&po | null | Y | 290021940 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 290004867 | 290003563 | 1.66 | 55.2 | Palliative (P) | 2013-08-09 | 2013-08-20 | OCTREOTIDE | 02 | N | 290021944 | EC |
| 290004868 | 290003564 | 1.55 | 60.4 | null | 2013-06-22 | 2013-08-08 | OCTREOTIDE | 02 | N | 290021947 | CAPECITABINE + RT |
| 290004869 | 290003565 | 1.77 | 77.6 | Palliative (P) | 2015-11-03 | 2015-11-03 | CARBOPLATIN + FLUOROURACIL | N | N | 290021950 | CISPLATIN + GEMCITABINE |
| 290004870 | 290003566 | 1.74 | 53.2 | Curative (C) | 2017-08-24 | 2017-08-27 | LANREOTIDE | 2 | Y | 290021951 | CARBOPLATIN + ETOPOSIDE |
| 290004871 | 290003566 | null | null | Palliative (P) | null | 2013-05-02 | CHOP R - 21 days | null | null | 290021951 | CETUXIMAB + RT |
| 290004872 | 290003566 | 1.49 | 48.8 | Curative (C) | 2016-03-05 | 2016-03-22 | Fluorouricil + Folonic Acid (MdG) | null | N | 290021951 | CAPECITABINE + RT |
| 290004873 | 290003566 | 1.78 | null | Curative (C) | 2014-11-24 | 2015-01-11 | PACLITAXEL + TRASTUZUMAB | N | N | 290021951 | LANREOTIDE |
| 290004874 | 290003567 | 1.74 | null | Adjuvant (A) | 2017-04-25 | 2017-04-28 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290021956 | CETUXIMAB + RT |
| 290004875 | 290003568 | 1.68 | null | Palliative (P) | 2016-03-27 | 2016-04-21 | Capecitabine + Cisplatin | N | N | 290021959 | TRIAL |
| 290004876 | 290003569 | 0 | 66.8 | Palliative (P) | 2016-01-05 | 2016-01-11 | Docetaxel | 02 | N | 290021960 | FLUOROURACIL |
| 290004877 | 290003570 | 1.52 | 53 | Neo-adjuvant (N) | 2014-01-01 | 2014-01-06 | Cisplatin + Docetaxel +Fluorouracil | 99 | N | 290021961 | EOX |
| 290004878 | 290003571 | null | 86.4 | Adjuvant (A) | 2017-12-09 | 2017-12-09 | Capecitabine | N | null | 290021963 | MCX |
| 290004879 | 290003571 | 1.75 | null | Adjuvant (A) | 2017-12-11 | 2018-01-04 | Capecitabine 35days + RT | N | null | 290021963 | GEMCITABINE |
| 290004880 | 290003571 | 0 | 35.8 | Palliative (P) | 2015-12-27 | 2015-12-27 | Capecitabine 35days + RT | 02 | N | 290021963 | CISPLATIN + ETOPOSIDE |
| 290004881 | 290003571 | null | 55.3 | null | 2016-08-02 | 2016-08-15 | ECX | 02 | null | 290021963 | CAPECITABINE |
| 290004882 | 290003572 | 1.77 | 56 | Palliative (P) | 2016-04-01 | 2016-04-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 290021968 | PEMBROLIZUMAB |
| 290004883 | 290003572 | null | null | Palliative (P) | null | 2017-07-10 | OCTREOTIDE | N | N | 290021968 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004884 | 290003572 | 1.62 | 82 | Palliative (P) | null | 2017-03-28 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 290021968 | CISPLATIN + FLUOROURACIL |
| 290004885 | 290003573 | 1.69 | 72.8 | null | 2017-01-28 | 2017-02-09 | Carboplatin + Etoposide iv&po | N | N | 290021972 | CAPECITABINE + CISPLATIN |
| 290004886 | 290003574 | null | null | Curative (C) | 2014-11-19 | 2014-12-01 | Capecitabine | 02 | Y | 290021973 | IVADO |
| 290004887 | 290003575 | 1.74 | 49.9 | Adjuvant (A) | 2014-08-26 | 2014-11-08 | EOF | N | Y | 290021976 | LANREOTIDE |
| 290004888 | 290006569 | 1.78 | 79.1 | Palliative (P) | null | 2017-10-13 | CARBOPLATIN + RT | N | N | 290021979 | PACLITAXEL |
| 290004889 | 290003576 | null | null | Neo-adjuvant (N) | null | 2017-12-15 | ECX | N | Y | 290021980 | CISPLATIN + FLUOROURACIL |
| 290004890 | 290003577 | 1.81 | 72.3 | Not known (9) | 2016-10-16 | 2016-10-16 | Dasatinib | 2 | null | 290021981 | CARBOPLATIN + ETOPOSIDE |
| 290004891 | 290003578 | 1.88 | 69 | Adjuvant (A) | 2013-10-20 | 2013-11-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290021984 | CETUXIMAB |
| 290004892 | 290003579 | 1.65 | 105.6 | Adjuvant (A) | 2016-08-29 | 2016-09-26 | Carboplatin + Pemetrexed | 02 | Y | 290021986 | CAPECITABINE |
| 290004893 | 290003580 | null | 72.7 | Palliative (P) | 2014-12-08 | 2014-12-08 | Irinotecan | 01 | N | 290021987 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290004894 | 290003581 | 1.62 | 110.3 | Adjuvant (A) | 2015-10-17 | 2015-10-17 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290021989 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004895 | 290006570 | 1.73 | 80 | null | 2015-07-05 | 2015-07-13 | OCTREOTIDE | 02 | null | 290021991 | CAPECITABINE + RT |
| 290004896 | 290006570 | 1.77 | null | Palliative (P) | null | 2018-04-21 | Capecitabine 42days + RT | null | null | 290021991 | CARBOPLATIN + CETUXIMAB + FU |
| 290004897 | 290003582 | 1.6 | 56.6 | Palliative (P) | 2013-05-21 | 2013-05-21 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | 290021993 | IPILIMUMAB |
| 290004898 | 290003582 | 1.6 | 77.9 | Adjuvant (A) | 2013-07-23 | 2013-07-29 | EOX | 2 | N | 290021993 | CAPECITABINE |
| 290004899 | 290003582 | 1.72 | 74.9 | Neo-adjuvant (N) | 2017-05-24 | 2017-06-03 | BENDAMUSTINE + RITUXIMAB | 2 | null | 290021993 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004900 | 290003582 | 1.66 | 81 | Neo-adjuvant (N) | 2013-10-15 | 2013-10-17 | Capecitabine | 01 | N | 290021993 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004901 | 290003583 | 1.69 | null | Disease modification (D) | 2014-11-22 | 2014-11-30 | FCarboSt | 02 | N | 290021998 | CISPLATIN + FLUOROURACIL |
| 290004902 | 290003584 | null | 43 | Neo-adjuvant (N) | 2017-07-15 | 2017-07-18 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290021999 | CETUXIMAB |